Celularity, a company spun out of biotech giant Celgene, announced this morning it has raised $250 million with the aim of developing cells from placentas to attack tumors and to treat Crohn’s disease. In addition to being awash in cash, the company is flooded with big dreams.
from Forbes Real Time https://www.forbes.com/sites/matthewherper/2018/02/15/celgene-spinout-celularity-raises-250-million-to-develop-placental-cells-to-attack-cancer/
via IFTTT
No comments:
Post a Comment